For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Syndax Pharmaceuticals Inc (NASDAQ: SNDX) closed at $13.07 down -1.80% from its previous closing price of $13.31. In other words, the price has decreased by -$1.80 from its previous closing price. On the day, 2.73 million shares were traded. SNDX stock price reached its highest trading level at $13.32 during the session, while it also had its lowest trading level at $12.91.
Ratios:
For a deeper understanding of Syndax Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.99 and its Current Ratio is at 6.99. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 24, 2024, initiated with a Buy rating and assigned the stock a target price of $37.
On June 28, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $37.
Scotiabank Downgraded its Sector Outperform to Sector Perform on January 31, 2024, whereas the target price for the stock was revised from $36 to $23.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 14 ’24 when Goldan Keith A. bought 1,250 shares for $20.03 per share. The transaction valued at 25,037 led to the insider holds 52,623 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNDX now has a Market Capitalization of 1115625088 and an Enterprise Value of 710937408. For the stock, the TTM Price-to-Sale (P/S) ratio is 68.47 while its Price-to-Book (P/B) ratio in mrq is 3.05. Its current Enterprise Value per Revenue stands at 44.434 whereas that against EBITDA is -2.213.
Stock Price History:
Over the past 52 weeks, SNDX has reached a high of $25.34, while it has fallen to a 52-week low of $12.75. The 50-Day Moving Average of the stock is -23.56%, while the 200-Day Moving Average is calculated to be -34.35%.
Shares Statistics:
For the past three months, SNDX has traded an average of 1.78M shares per day and 3547650 over the past ten days. A total of 85.57M shares are outstanding, with a floating share count of 81.08M. Insiders hold about 5.02% of the company’s shares, while institutions hold 100.30% stake in the company. Shares short for SNDX as of 1732838400 were 14396481 with a Short Ratio of 9.17, compared to 1730332800 on 10657597. Therefore, it implies a Short% of Shares Outstanding of 14396481 and a Short% of Float of 17.0.
